Amphetamine and pentylenetetrazole given post-trial 1 enhance one-trial tolerance to the anxiolytic effect of diazepam in the elevated plus-maze in mice

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 30, Issue 8, 2006, Pages 1394-1402

  Vargas, Kleber Meneghel ^a   Da Cunha, Cláudio ^a   Andreatini, Roberto ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

Anxiety; Diazepam; Learning; Memory; Pentylenetetrazole; Plus maze

Indexed keywords

AMPHETAMINE; DIAZEPAM; PENTETRAZOLE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DRUG EFFECT; LEARNING; MALE; MAZE TEST; MEMORY; MEMORY CONSOLIDATION; MOUSE; NONHUMAN; STATISTICAL SIGNIFICANCE; TRAINING; TRANQUILIZING ACTIVITY;

AMPHETAMINE; ANIMALS; ANTI-ANXIETY AGENTS; DIAZEPAM; DRUG ADMINISTRATION SCHEDULE; DRUG TOLERANCE; MAZE LEARNING; MEMORY; MICE; MODELS, ANIMAL; PENTYLENETETRAZOLE; REACTION TIME;

EID: 33750992197     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2006.05.004     Document Type: Article

References (58)

1. Albrechet-Souza L., Oliveira A.R., De Luca M.C., Tomazini F.M., Santos N.R., and Brandao M.L. A comparative study with two types of elevated plus-maze (transparent vs. opaque walls) on the anxiolytic effects of midazolam, one-trial tolerance and fear-induced analgesia. Prog Neuropsychopharmacol Biol Psychiatry 29 4 (2005) 571-579
2. Andreatini R., and Bacellar L.F. The relationship between anxiety and depression in animal models: a study using the forced swimming test and elevated plus-maze. Braz J Med Biol Res 32 9 (1999) 1121-1126
3. Andreatini R., Vital M.A.B.F., and Santos G.L. The reinstatement of conflict reverses the one-trial tolerance to diazepam on elevated plus-maze. Eur Neuropsychopharmacol 13 suppl 4 (2003) S378-S379
4. Bertoglio L.J., and Carobrez A.P. Prior maze experience required to alter midazolam effects in rats submitted to the elevated plus-maze. Pharmacol Biochem Behav 72 (2002) 449-455
5. Bertoglio L.J., and Carobrez A.P. Anxiolytic effects of ethanol and phenobarbital are abolished in test-experienced rats submitted to the elevated plus maze. Pharmacol Biochem Behav 73 (2002) 963-969
6. Bertoglio L.J., and Carobrez A.P. Behavioral profile of rats submitted to session 1-session 2 in the elevated plus-maze during diurnal/nocturnal phases and under different illumination conditions. Behav Brain Res 132 (2002) 135-143
7. Bertoglio L.J., and Carobrez A.P. Scopolamine given pre-trial 1 prevents the one-trial tolerance phenomenon in the elevated plus-maze trial 2. Behav Pharmacol 15 (2004) 45-54
8. Bertoglio L.J., and Carobrez A.P. Ethological and temporal analysis of anxiety-like behavior: the elevated plus-maze model 20 years on. Neurosci Biobehav Rev 29 8 (2005) 1193-1205
9. Calvazara M.B., Patti C.L., Lopez G.B., Abílio V.C., Silva R.H., and Frussa-Filho R. Role of learning of open arm avoidance in the phenomenon of one-trial tolerance to the anxiolytic effect of chlordiazepoxide in mice. Life Sci 76 (2005) 2235-2246
10. Cardenas, F, Lamprea, M, Morato, S. X-Plo-Rat: a free software for behavior recording. 2001; available from: http://geocites.com/xplorat.
11. Castellano C. Cocaine, pemolide and amphetamine on learning and retention of a discrimination test in mice. Psychopharmacologia 36 (1974) 67-76
12. Castellano C., Cabib S., and Puglisi-Allegra S. Psychopharmacology of memory modulation: evidence for multiple interaction among neurotransmitters and hormones. Behav Brain Res 77 1-2 (1996) 1-21
13. Chacur C., Raymond R., Hipolide D.C., Giugliano E.B., Leite J.R., and Nobrega J.N. Immediate increase in benzodiazepine binding in rat brain after a single brief experience in the plus maze: a paradoxical effect. Neurosci Lett 269 (1999) 29-32
14. Cole J.C., and Rodgers R.J. An ethological analysis of the effects of chlordiazepoxide and bretazenil (Ro 16-6028) in the murine elevated plus-maze. Behav Pharmacol 4 (1993) 573-580
15. Comissaris R.L. Conflict behaviors as animal models for the study of anxiety. In: van Haaren F. (Ed). Methods in behavioral pharmacology (1993), Elsevier, Amsterdam 443-474
16. Cook L., and Davidson A.R. Effects of behaviorally active drugs in a conflict-punishment procedure in rats. In: Garattini S., Mussimi E., and Randall L.O. (Eds). The benzodiazepines (1973), Raven Press, New York 327-345
17. Cruz-Morales S.E., Santos N.R., and Brandao M.L. One-trial tolerance to midazolam is due to enhancement of fear and reduction of anxiolytic-sensitive behaviors in the elevated plus-maze retest in the rat. Pharmacol Biochem Behav 72 (2002) 973-978
18. Dal-Cól M.L.C., Orlandi Pereira L., Rosa V.P., Calixto A.V., Carobrez A.P., and Faria M.S. Lack of midazolam-induced anxiolysis in the plus-maze trial 2 is dependent on the length of trial 1. Pharmacol Biochem Behav 74 (2003) 395-400
19. Dawson G.R., Crawford S.P., Stanhope K.J., Iversen S.D., and Triclebank M.D. One-trial tolerance to the effects of chlordiazepoxide on the elevated plus-maze may be due to locomotor habituation, not repeated drug exposure. Psychopharmacology 113 (1994) 570-572
20. Falter U., Gower A.J., and Gobert J. Resistance of baseline activity in the elevated plus-maze to exogenous influence. Behav Pharmacol 3 (1992) 123-128
21. File S.E. One trial tolerance to the anxiolytic effects of chlordiazepoxide in the plus-maze. Psychopharmacology 100 (1990) 281-282
22. A receptors and anxiety: from neurobiology to treatment (1995), Raven Press, New York 93-113
23. File S.E., and Zangrossi H. "One-trial tolerance" to the anxiolytic actions of benzodiazepines in the elevated plus-maze, or the development of a phobic state?. Psychopharmacology 110 (1993) 240-244
24. File S.E., Mabbut P.S., and Hitchocott P.K. Characterization of the phenomenon of "one-trial tolerance" to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze. Psychopharmacology 102 (1990) 98-101
25. File S.E., Andrews N., Wu P.Y., Zharkovsky A., and Zangrossi Jr. H. Modification of chlordiazepoxide's behavioural and neurochemical effects by handling and plus-maze experience. Eur J Pharmacol 218 (1992) 9-14
26. File S.E., Zangrossi H., Viana M., and Graeff F. Trial 2 in the elevated plus-maze: a different form of fear?. Psychopharmacology 111 (1993) 491-494
27. File S.E., Zangrossi Jr. H., Sanders F.L., and Mabutt P.S. Raised corticosterone in the rat after exposure to the elevated plus-maze. Psychopharmacology 113 3-4 (1994) 543-546
28. File S.E., Gonzalez L.E., and Gallant R. Role of the basolateral nucleus of the amygdala in the formation of a phobia. Neuropsychopharmacology 19 (1998) 397-405
29. File S.E., Gonzalez L.E., and Gallant R. Role of the dorsomedial hypothalamus in mediating the response to benzodiazepines on trial 2 in the elevated plus-maze test of anxiety. Neuropsychopharmacology 21 2 (1999) 312-320
30. Frussa-Filho R., and Ribeiro R.D. One-trial tolerance to the effects of chlordiazepoxide in the elevated plus-maze is not due to acquisition of a phobic avoidance of open arms during initial exposure. Life Sci 71 (2002) 519-525
31. Gonzalez L.E., and File S.E. A five minute experience in the elevated plus-maze alters the state of the benzodiazepine receptor in the dorsal raphe nucleus. J Neuroscience 17 (1997) 1505-1511
32. Graeff F.G., Netto C.F., and Zangrossi Jr. H. The elevated T-maze as an experimental model of anxiety. Neurosci Biobehav Rev 23 2 (1998) 237-246
33. Holmes A., and Rodgers R.J. Responses of Swiss-Webster mice to repeated plus-maze experience: further evidence for a qualitative shift in emotional state?. Pharmacol Biochem Behav 60 (1998) 473-488
34. Holmes A., and Rodgers R.J. Influence of spatial and temporal manipulations on the anxiolytic efficacy of chlordiazepoxide in mice previously exposed to the elevated plus-maze. Neurosci Biobehav Rev 23 (1999) 971-980
35. Itoh J., Nabeshima T., and Kameyama T. Utility of an elevated plus-maze for the evaluation of memory in mice: effects of nootropics, scopolamine and electroconvulsive shock. Psychopharmacology 101 1 (1990) 27-33
36. Janak P.H., and Martinez Jr. J.L. Cocaine and amphetamine facilitate retention of jump-up responding in rats. Pharmacol Biochem Behav 41 (1992) 837-840
37. Krivanek J.A. Facilitation of avoidance learning by pentylenetetrazol as a function of task difficulty, deprivation and shock level. Psychopharmarcologia 20 (1971) 213-229
38. Krivanek J.A., and McGaugh J.L. Effects of pentylenetetrazol on memory storage in mice. Psychopharmacologia 12 (1968) 303-321
39. Lamprea M.R., Cardenas F.P., Silveira R., Morato S., and Walsh T.J. Dissociation of memory and anxiety in a repeated elevated plus-maze paradigm: forebrain cholinergic mechanisms. Behav Brain Res 117 (2000) 97-105
40. Lister R.G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 92 (1987) 180-185
41. Martijena I.D., Calvo N., Volosin M., and Molina V.A. Prior exposure to a brief restraint session facilitates the occurrence of fear in response to a conflict situation: behavioral and neurochemical correlates. Brain Res 752 1-2 (1997) 136-142
42. Martinez Jr. J.L., Jensen R.A., Messing R.B., Vasquez B.J., Soumireu-Mourat B., Geddes D., et al. Central and peripheral actions of amphetamine on memory storage. Brain Res 182 1 (1980) 157-166
43. McGaugh J.L. The amygdala modulates the consolidation of memories of emotionally arousing experiences. Annu Rev Neurosci 27 (2004) 1-28
44. Menard J., and Treit D. Does tolerance develop to the anxiolytic effects of septal lesions?. Physiol Behav 59 (1996) 311-318
45. Nestler E.J., Hyman S.E., and Malenka R.C. Molecular neuropharmacology: a foundation for clinical neuroscience. 1st edition (2001), McGraw-Hill, New York
46. Nunes-de-Souza R.L., Canto-de-Souza A., and Rodgers R.J. Effects of intrahippocampal infusion of WAY-100635 on plus-maze behavior in mice: influence of site of injection and prior test experience. Brain Res 927 (2002) 87-96
47. Pellow S., Chopin P., File S., and Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14 (1985) 149-167
48. Pereira J.K.D., Vieira R.J., Konishi C.T., Ribeiro R.D., and Frussa-Filho R. The phenomenon of "one-trial tolerance" to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze is abolished by the introduction of a motivational conflict situation. Life Sci 65 (1999) PL101-PL107
49. Platel A., and Porsolt R.D. Habituation of exploratory activity in mice: a screening test for memory enhancing drugs. Psychopharmacology 78 (1982) 346-352
50. Rodgers R.J., and Shepherd J.K. Influence of prior maze experience on behavior and response to diazepam in the elevated plus-maze and light-dark tests of anxiety in mice. Psychopharmacology 113 (1993) 237-242
51. Rodgers R.J., and Cole J.C. The elevated plus-maze: pharmacology, methodology and ethology. In: Cooper S.J., and Hendrie C.A. (Eds). Ethology and psychopharmacology (1994), John Wiley, Chichester 9-44
52. Rodgers R.J., Cole J.C., and Harrison-Phillips D.J. "Cohort removal" induces hyperthermia but fails to influence plus-maze behaviour in male mice. Physiol Behav 55 1 (1994) 189-192
53. Rodgers R.J., Johnson N.J., Cole J.C., Dewar C.V., Kidd G.R., and Kimpson P.H. Plus-maze retest profile in mice: importance of initial stages of trial 1 and response to post-trial cholinergic receptor blockade. Pharmacol Biochem Behav 54 1 (1996) 41-50
54. Rodgers R.J., Johnson N.J.T., Carr J., and Hodgson T.P. Resistance of experientially-induced changes in murine plus-maze behaviour to altered retest conditions. Behav Brain Res 86 (1997) 71-77
55. Roozendaal B., Carmi O., and McGaugh J.L. Adrenocortical suppression blocks the memory-enhancing effects of amphetamine and epinephrine. Proc Natl Acad Sci 93 4 (1996) 1429-1433
56. Rosa V.P., Vandresen N., Calixto A.V., Kovaleski D.F., and Faria M.S. Temporal analysis of the rat's behavior in the plus-maze: effect of midazolam. Pharmacol Biochem Behav 67 (2000) 177-182
57. Strupp B.J., Bunsey M., Levitsky D., and Kesler M. Time-dependent effects of post-trial amphetamine treatment in rats: evidence for enhanced storage of representational memory. Behav Neural Biol 56 1 (1991) 62-76
58. Treit D., Menard J., and Royan C. Anxiogenic stimuli in the elevated plus-maze. Pharmacol Biochem Behav 44 (1993) 463-469